In the United States Court of Federal Claims
                             OFFICE OF SPECIAL MASTERS

 ********************                         *      No. 16-318V
 JESSICA R. MARTIN,                           *      Special Master Christian J. Moran
 On behalf of KM,                             *      Filed: October 23, 2017
                                              *
                       Petitioner,            *
 v.                                           *      Stipulation; diphtheria-tetanus-
                                              *      acellular pertussis (DTaP);
 SECRETARY OF HEALTH AND                      *      inactivated poliovirus (IPV);
 HUMAN SERVICES,                              *      Haemophilus influenza type B
                                              *      (Hib); pneumococcal conjugate
                       Respondent.            *      (PCV); rotavirus; transverse
                                              *      myelitis.
 ********************                         *

Dan W. Bolton, III, Bolton Law, PLLC, Cary, NC, for Petitioner;
Voris E. Johnson, Jr., United States Dep’t of Justice, Washington, DC, for
                                                     Respondent.

                             UNPUBLISHED DECISION1

       On October 20, 2017, the parties filed a joint stipulation concerning the
petition for compensation filed by Jessica R. Martin, on behalf of KM, on March
11, 2016. In her petition, petitioner alleged that the diphtheria-tetanus-acellular
pertussis (DTaP), inactivated poliovirus (IPV), Haemophilus influenza type B
(Hib), pneumococcal conjugate (PCV) and rotavirus vaccines, which are contained
in the Vaccine Injury Table, 42 C.F.R. §100.3(a), and which KM received on
August 23, 2013, caused KM to suffer transverse myelitis (“TM”). Petitioner
further alleges that KM suffered the residual effects of this injury for more than six
months. Petitioner represents that there has been no prior award or settlement of a
civil action for damages on KM’s behalf as a result of KM’s condition.

       1
         The E-Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and
Promotion of Electronic Government Services), requires that the Court post this decision on its
website. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing
redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4).
Any redactions ordered by the special master will appear in the document posted on the website.
      Respondent denies that the influenza vaccine caused KM to suffer TM or
any other injury. Nevertheless, the parties agree to the joint stipulation, attached
hereto. The undersigned finds said stipulation reasonable and adopts it as the
decision of the Court in awarding damages, on the terms set forth therein.

       Damages awarded in that stipulation include:

       1. A lump sum payment of $250,000.00 in the form of a check payable
          to petitioner as court-appointed guardian/conservator of the estate of
          KM. However, no payments shall be made until petitioner provides
          respondent with documentation establishing that she has been
          appointed as guardian/conservator of KM’s estate;

       2. A lump sum of $9,500.00, which amount represents compensation of
          past unreimbursable expenses, in the form of a check payable to
          petitioner, Jessica R. Martin; and,

       3. An amount sufficient to purchase the annuity contract described in
          paragraph 10 of the attached stipulation agreement, paid to the life
          insurance company from which the annuity will be purchased.

These amounts represent compensation for all damages that would be available
under 42 U.S.C. § 300aa-15(a).

       In the absence of a motion for review filed pursuant to RCFC, Appendix B,
the clerk is directed to enter judgment in case 16-318V according to this decision
and the attached stipulation.2

       IT IS SO ORDERED.

                                                     S/Christian J. Moran
                                                     Christian J. Moran
                                                     Special Master



       2
          Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each
party filing a notice renouncing the right to seek review by a United States Court of Federal
Claims judge.
                                                2
                IN THE UNITED STATES COURT OF FEDERAL CLAIMS

                               OFFICE OF SPECIAL MASTERS

JESSICA R. MARTIN,                                 )
On behalf of KM,                                   )
                                                   )
                      Petitioner,                  )
v.                                                 )    No. 16-318V
                                                   )    Special Master Moran
SECRETARY OF HEALTH AND HUMAN                      )
SERVICES,                                          )
                                                   )
                Respondent.                        )
                                                   )

                                         STIPULATION

        The parties hereby stipulate to the following matters:

        1. Jessica R. Martin (“petitioner”), on behalf of her minor daughter, KM, filed a petition

for vaccine compensation under the National Vaccine Injury Compensation Program, 42 U.S.C.

§300aa-10 to 34 (the “Vaccine Program”). The petition seeks compensation for injuries

allegedly related to KM’s receipt of diphtheria-tetanus-acellular pertussis (DTaP), inactivated

poliovirus (IPV), Haemophilus influenza type B (Hib), pneumococcal conjugate (PCV) and

rotavirus vaccines, which vaccines are contained in the Vaccine Injury Table (the “Table”), 42

C.F.R. § 100.3 (a).

        2. KM received the DTaP, IPV, Hib, PCV and rotavirus immunizations on August 23,

2013.

        3. The vaccines were administered within the United States.

        4. Petitioner alleges that KM suffered from transverse myelitis (“TM”) as a result of

receiving the above-referenced vaccines. Petitioner further alleges that KM has suffered the

residual effects of her TM for more than six months.
       5. Petitioner represents that there has been no prior award or settlement of a civil action

for damages on behalf of KM as a result of her condition.

       6. Respondent denies that the vaccines caused KM to suffer from TM, or any other

injury or her current condition.

       7. Maintaining their above-stated positions, the parties nevertheless now agree that the

issues between them shall be settled and that a decision should be entered awarding the

compensation described in paragraph 8 of this Stipulation.

       8. As soon as practicable after an entry of judgment reflecting a decision consistent with

the terms of this Stipulation, and after petitioner has filed an election to receive compensation

pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue

the following vaccine compensation payments:

       a. A lump sum of $250,000.00, in the form of a check payable to petitioner as court-
       appointed guardian/conservator of the estate of KM, for the benefit of KM. No payments
       shall be made until petitioner provides respondent with documentation establishing that
       she has been appointed as guardian/conservator of KM’s estate;

       b. A lump sum of $9,500.00, which amount represents compensation for past
       unreimbursable expenses, in the form of a check payable to petitioner, Jessica R. Martin;
       and,

       c. An amount sufficient to purchase the annuity contract described in paragraph 10
       below, paid to the life insurance company from which the annuity will be purchased (the
       “Life Insurance Company”).

These amounts represent compensation for all damages that would be available under 42

U.S.C. § 300aa-15(a).

       9. The Life Insurance Company must have a minimum of $250,000,000.00 capital and

surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company

must have one of the following ratings from two of the following rating organizations:

       a.      A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s;



                                                 2
       b.      Moody’s Investor Service Claims Paying Rating: Aa3, Aa2, Aa1, or Aaa;

       c.      Standard and Poor’s Corporation Insurer Claims-Paying Ability Rating: AA-,
               AA, AA+, or AAA;

       d.      Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating:
               AA-, AA, AA+, or AAA.

       10. The Secretary of Health and Human Services agrees to purchase an annuity contract

from the Life Insurance Company for the benefit of KM, pursuant to which the Life Insurance

Company will agree to make payments periodically to petitioner, as the court-appointed

guardian/conservator of the estate of KM, as follows:

       Beginning as soon as practicable after the date of judgment, $990.12 per month for life
       only, increasing at three percent (3%), compounded annually from the date payments
       begin.

The payments provided for in this paragraph 10 shall be made as set forth above. Petitioner will

continue to receive the annuity payments from the Life Insurance Company only so long as KM

is alive at the time that a particular payment is due. Written notice to the Secretary of Health and

Human Services, and the Life Insurance Company shall be provided within twenty (20) days of

KM’s death.

       11. The annuity contract will be owned solely and exclusively by the Secretary of Health

and Human Services and will be purchased as soon as practicable following the entry of a

judgment in conformity with this Stipulation. The parties stipulate and agree that the Secretary

of Health and Human Services and the United States of America are not responsible for the

payment of any sums other than the amounts set forth in paragraph 8 herein and the amounts

awarded pursuant to paragraph 12 herein, and that they do not guarantee or insure any of the

future annuity payments. Upon the purchase of the annuity contract, the Secretary of Health and




                                                 3
Human Services and the United States of America are released from any and all obligations with

respect to future annuity payments.

        12. As soon as practicable after the entry of judgment on entitlement in this case, and

after petitioner has filed both a proper and timely election to receive compensation pursuant to

42 U.S.C. § 300aa-21(a)(1), and an application, the parties will submit to further proceedings

before the special master to award reasonable attorneys’ fees and costs incurred in proceeding

upon this petition.

        13. Petitioner and her attorney represent that compensation to be provided pursuant to

this Stipulation is not for any items or services for which the Program is not primarily liable

under 42 U.S.C. § 300aa-15(g), to the extent that payment has been made or can reasonably be

expected to be made under any State compensation programs, insurance policies, Federal or

State health benefits programs (other than Title XIX of the Social Security Act (42 U.S.C. §

1396 et seq.)), or by entities that provide health services on a pre-paid basis.

        14. Payments made pursuant to paragraph 8 and any amounts awarded pursuant to

paragraph 12 of this Stipulation will be made in accordance with 42 U.S.C. § 300aa-15(i),

subject to the availability of sufficient statutory funds.

        15. The parties and their attorneys further agree and stipulate that, except for any award

for attorneys’ fees and litigation costs, and petitioner’s past expenses, the money provided

pursuant to this Stipulation will be used solely for the benefit of KM as contemplated by a strict

construction of 42 U.S.C. §300aa-15(a) and (d), and subject to the conditions of 42 U.S.C. §

300aa-15(g) and (h).

        16. Petitioner represents that she presently is, or within 90 days of the date of judgment

will become, duly authorized to serve as guardian/conservator of KM’s estate under the laws of



                                                   4
the State of North Carolina. No payments pursuant to this Stipulation shall be made until

petitioner provides the Secretary with documentation establishing her appointment as

guardian/conservator of KM’s estate. If petitioner is not authorized by a court of competent

jurisdiction to serve as guardian/conservator of the estate of KM at the time a payment pursuant

to this Stipulation is to be made, any such payment shall be paid to the party or parties appointed

by a court of competent jurisdiction to serve as guardian(s)/conservator(s) of the estate of KM

upon submission of written documentation of such appointment to the Secretary.

       17. In return for the payments described in paragraphs 8 and 12, petitioner, in her

individual capacity and as legal representative of KM, on behalf of herself, KM, and KM’s heirs,

executors, administrators, successors or assigns, does forever irrevocably and unconditionally

release, acquit and discharge the United States and the Secretary of Health and Human Services

from any and all actions or causes of action (including agreements, judgments, claims, damages,

loss of services, expenses and all demands of whatever kind or nature) that have been brought,

could have been brought, or could be timely brought in the Court of Federal Claims, under the

National Vaccine Injury Compensation Program, 42 U.S.C. § 300 aa-10 et seq., on account of, or

in any way growing out of, any and all known or unknown, suspected or unsuspected personal

injuries to or death of KM resulting from, or alleged to have resulted from the DTaP, IPV, Hib,

PCV and rotavirus vaccinations administered on August 23, 2013, as alleged by petitioner in a

petition for vaccine compensation filed on or about March 11, 2016, in the United States Court

of Federal Claims as petition No. 16-318V.

       18. If KM should die prior to entry of judgment, this agreement shall be voidable upon

proper notice to the Court on behalf of either or both of the parties.




                                                  5
       19. If the special master fails to issue a decision in complete conformity with the terms

of this Stipulation or if the Court of Federal Claims fails to enter judgment in conformity with a

decision that is in complete conformity with the terms of this Stipulation, then the parties’

settlement and this Stipulation shall be voidable at the sole discretion of either party.

       20. This Stipulation expresses a full and complete negotiated settlement of liability and

damages claimed under the National Childhood Vaccine Injury Act of 1986, as amended, except

as otherwise noted in paragraph 12 above. There is absolutely no agreement on the part of the

parties hereto to make any payment or to do any act or thing other than is herein expressly stated

and clearly agreed to. The parties further agree and understand that the award described in this

Stipulation may reflect a compromise of the parties’ respective positions as to liability and/or

amount of damages, and further, that a change in the nature of the injury or condition or in the

items of compensation sought, is not grounds to modify or revise this agreement.

       21. Petitioner hereby authorizes respondent to disclose documents filed by petitioner in

this case consistent with the Privacy Act and the routine uses described in the National Vaccine

Injury Compensation Program System of Records, No. 09-15-0056.

       22. This Stipulation shall not be construed as an admission by the United States or the

Secretary of Health and Human Services that the DTaP, IPV, Hib, PCV or rotavirus vaccines

caused KM to suffer from TM, or any other injury or condition.

       23. All rights and obligations of petitioner hereunder shall apply equally to petitioner’s

heirs, executors, administrators, successors, and/or assigns as legal representatives of KM.

                                   END OF STIPULATION




                                                  6
